Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR – Get Free Report)’s share price passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $1.95 and traded as low as $1.9450. Organicell Regenerative Medicine shares last traded at $1.99, with a volume of 302 shares.
Organicell Regenerative Medicine Trading Up 7.6%
The company’s 50-day simple moving average is $1.95 and its two-hundred day simple moving average is $1.81.
Organicell Regenerative Medicine Company Profile
Organicell Regenerative Medicine, Inc is a clinical‐stage biotechnology company dedicated to the development and commercialization of cell and exosome‐based therapeutics for a variety of inflammatory and degenerative medical conditions. Leveraging its proprietary placental and amniotic tissue–derived platform, the company isolates and purifies extracellular vesicles (EVs) and mesenchymal‐like cells, which are studied for their ability to modulate immune response and promote tissue repair. With an emphasis on regenerative medicine, Organicell’s research efforts aim to translate novel biologics into scalable treatments.
The company’s pipeline is anchored by exosome‐centered product candidates that target pulmonary, ophthalmic, and musculoskeletal indications.
See Also
- Five stocks we like better than Organicell Regenerative Medicine
- The boring AI play that could pay up to $4,290 monthly
- Trump’s “real estate deal for America” explained
- Put $1,000 into this stock by Jan 1 [Not NVDA]
- Trump Did WHAT??
- A month before the crash
Receive News & Ratings for Organicell Regenerative Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organicell Regenerative Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
